A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

Volume 326:793-798		March 19, 1992		Number 12

WG Powderly, MS Saag, GA Cloud, P Robinson, RD Meyer, JM Jacobson, JR Graybill, AM Sugar, VJ McAuliffe, SE Follansbee, and et al.

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110.

This article has been cited by other articles:

Karam, G. H. (2009). Infections in AIDS Patients and Other Immunocompromised Hosts. ACCP Crit Care Med Brd Rev 20: 13-40 [Full Text]
Duffalo, M. L. (2006). Fungal Opportunistic Infections in HIV Disease. Journal of Pharmacy Practice 19: 17-30 [Abstract]
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H. (2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother. 48: 693-715 [Full Text]
Masur, P. b. H., Kaplan, J. E., Holmes, K. K. (2002). Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons--2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. ANN INTERN MED 137: 435-478 [Abstract] [Full Text]
Purdy, B. D. (2000). Management and Prevention of Opportunistic Infections in the HIV-Infected Patient. Journal of Pharmacy Practice 13: 475-498 [Abstract]
Aller, A. I., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F. J., Espinel-Ingroff, A. (2000). Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection. Antimicrob. Agents Chemother. 44: 1544-1548 [Abstract] [Full Text]
Kovacs, J. A., Masur, H. (2000). Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection. NEJM 342: 1416-1429 [Full Text]
Cabre, P, Smadja, D, Cabié, A, Newton, C R J C (2000). NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: HTLV-1 and HIV infections of the central nervous system in tropical areas. J. Neurol. Neurosurg. Psychiatry 68: 550-557 [Full Text]
Shih, C.-C., Chen, Y.-C., Chang, S.-C., Luh, K.-T., Hsieh, W.-C. (2000). Cryptococcal meningitis in non-HIV-infected patients. QJM 93: 245-251 [Abstract] [Full Text]
Sheehan, D. J., Hitchcock, C. A., Sibley, C. M. (1999). Current and Emerging Azole Antifungal Agents. Clin. Microbiol. Rev. 12: 40-79 [Abstract] [Full Text]
Pfaller, M. A., Zhang, J., Messer, S. A., Brandt, M. E., Hajjeh, R. A., Jessup, C. J., Tumberland, M., Mbidde, E. K., Ghannoum, M. A. (1999). In Vitro Activities of Voriconazole, Fluconazole, and Itraconazole against 566�Clinical Isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob. Agents Chemother. 43: 169-171 [Abstract] [Full Text]
Schell, W. A., De Almeida, G. M. D., Dodge, R. K., Okonogi, K., Perfect, J. R. (1998). In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 42: 2630-2632 [Abstract] [Full Text]
Scharfstein, J. A., Paltiel, A. D., Freedberg, K. A. (1997). The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients. Med Decis Making 17: 373-381 [Abstract]
Manfredi, R., Mastroianni, A., Coronado, O. V., Chiodo, F. (1997). Fluconazole as Prophylaxis Against Fungal Infection in Patients With Advanced HIV Infection. Arch Intern Med 157: 64-69 [Abstract]
Murakawa, G. J., Kerschmann, R., Berger, T. (1996). Cutaneous Cryptococcus Infection and AIDS: Report of 12 Cases and Review of the Literature. Arch Dermatol 132: 545-548 [Abstract]
Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., Hooton, T. M., Hyslop, N., Spector, S. A., Bozzette, S. A., The NIAID AIDS Clinical Trials Group, (1995). A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection. NEJM 332: 700-705 [Abstract] [Full Text]
Fishman, J.A., Mattia, A.R. (1995). Case 3-1995- A 29-year-old man with AIDS and multiple splenic abscesses. NEJM 332: 249-257 [Full Text]
Moore, R. D., Stanton, D., Gopalan, R., Chaisson, R. E. (1994). Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community. NEJM 330: 763-768 [Abstract] [Full Text]
Sax, P. E., Mattia, A. R. (1994). Case 7-1994- A 55-Year-Old Heart-Transplant Recipient with a Tender, Enlarged Prostate Gland. NEJM 330: 490-496 [Full Text]
Como, J. A., Dismukes, W. E. (1994). Oral Azole Drugs as Systemic Antifungal Therapy. NEJM 330: 263-272 [Full Text]
Girard, P.-M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Boue, F., Bouvet, E., Lecompte, T., Jean-Coulaud, P., The PRIO Study Group, (1993). Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection. NEJM 328: 1514-1520 [Abstract] [Full Text]
Jewett, J. F., Hecht, F. M. (1993). Preventive Health Care for Adults With HIV Infection. JAMA 269: 1144-1153 [Abstract]

Comments and questions? Please contact us.